Stocksigma LogoStocksigma Logo

Symbiotec Pharmalab Adopts Code of Fair Disclosure for UPSI Under SEBI Regulations

On 3rd Sep'26, Symbiotec Pharmalab filed its Code of Practices for Fair Disclosure of Unpublished Price Sensitive Information (UPSI), effective 15th

Symbiotec Pharmalab Adopts Code of Fair Disclosure for UPSI Under SEBI Regulations

Symbiotec Pharmalab Ltd 路 Others (Uncategorized) 路 03 Sept 2026, 7:17 pm

Symbiotec Pharmalab Adopts Code of Fair Disclosure for UPSI Under SEBI Regulations On 3rd Sep'26, Symbiotec Pharmalab filed its Code of Practices for Fair Disclosure of Unpublished Price Sensitive Information (UPSI), effective 15th Dec'25. Mandated by SEBI, the policy enforces prompt, universal dissemination of price-sensitive data and strict confidentiality on a need-to-know basis for legitimate business purposes. To ensure strict compliance and transparency, the Board appointed a Chief Investor Relations Officer (CIRO) reporting directly to the CFO. The CIRO will exclusively oversee UPSI disclosure, verify market rumors, and manage all official communications with stock exchanges and media.

Original exchange filing (PDF)

More announcements from Symbiotec Pharmalab Ltd

All Symbiotec Pharmalab Ltd announcements